Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.91 USD | -1.52% | -4.73% | -19.13% |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Apr. 10 | Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform | MT |
Financials (USD)
Sales 2024 * | 631M | Sales 2025 * | 768M | Capitalization | 6.05B |
---|---|---|---|---|---|
Net income 2024 * | -576M | Net income 2025 * | -514M | EV / Sales 2024 * | 9.41 x |
Net cash position 2024 * | 111M | Net Debt 2025 * | 223M | EV / Sales 2025 * | 8.17 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-12
x | Employees | 927 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.14% |
Latest transcript on Ionis Pharmaceuticals, Inc.
1 day | -1.52% | ||
1 week | -4.73% | ||
Current month | -5.63% | ||
1 month | -2.66% | ||
3 months | -20.24% | ||
6 months | -15.67% | ||
Current year | -19.13% |
Managers | Title | Age | Since |
---|---|---|---|
D. Walke
FOU | Founder | 58 | 12-06-30 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 62 | 00-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Loscalzo
CHM | Chairman | 72 | 14-02-02 |
Brett Monia
FOU | Founder | 62 | 89-01-09 |
Joan Herman
BRD | Director/Board Member | 70 | 19-06-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
6.89% | 1 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-17 | 40.91 | -1.52% | 1 143 841 |
24-04-16 | 41.54 | -0.02% | 1,101,462 |
24-04-15 | 41.55 | -0.46% | 789,558 |
24-04-12 | 41.74 | -1.79% | 829,857 |
24-04-11 | 42.5 | -1.02% | 869,815 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.13% | 6.05B | |
-1.78% | 41.71B | |
+47.70% | 41.56B | |
+4.01% | 39.74B | |
-15.14% | 25.61B | |
+3.16% | 24.26B | |
-24.08% | 18.55B | |
-2.67% | 11.93B | |
+24.76% | 11.93B | |
+7.01% | 10.91B |
- Stock Market
- Equities
- IONS Stock